The lectin complement pathway and Ficolin-2 in patients with necrotizing soft tissue infection

Marco Bo Hansen,Lars Simon Rasmussen,Katrine Pilely,Dorthe Hellemann,Estrid Hein,Martin Bruun Madsen,Ole Hyldegaard,Peter Garred
DOI: https://doi.org/10.4049/jimmunol.196.supp.124.39
2016-05-01
The Journal of Immunology
Abstract:Abstract Background Mannose-binding lectin (MBL) and ficolins are pattern recognition molecules (PRMs) that play an important role during infection through activation of the lectin complement pathway. We assessed whether blood concentrations of the PRMs were associated with mortality in patients with necrotizing soft tissue infection (NSTI). Methods We conducted a prospective, observational study over 25 months involving 135 NSTI patients with a maximum follow-up time of 2.7 years. Plasma PRM level were measured upon admission. Non-infected surgical patients served as controls. Results PRMs levels of the lectin complement pathway were significantly lower compared to non-infected patients. Ficolin-2 level below median was associated with mortality at the end of follow-up (p = 0.007, log-rank), whereas no significant association was found for MBL, Ficolin-1 and Ficolin-3. Ficolin-2 level below median had a positive predictive value of 0.27 and a negative predictive value of 0.94 for 28-day mortality. When optimal cut-off was used, the multivariate cox-regression analysis revealed that low Ficolin-2 level was independently associated with 28-day mortality when adjusted for age, gender and chronicity (HR 6.27 [95% CI, 2.28–17.21], p < 0.0001) and also when SAPS II was included (HR 3.16 [95% CI, 1.03–9.73], p = 0.045). Conclusions All PRMs of the lectin complement pathway were significantly lower in patients with NSTI than in non-infected controls upon admission. Only plasma Ficolin-2 was significantly associated with both short-term and long-term mortality. Additionally, a high Ficolin-2 level above the median indicated a 94% chance of surviving the first 28 days after admission. ClinicalTrials.gov Identifier: NCT2180906.
immunology
What problem does this paper attempt to address?